Abstract:Ubiquitin-like proteins (UBLs) constitute a family of evolutionarily conserved proteins that share similarities with ubiquitin in 3D structures and modification mechanisms. For most UBLs including Small-Ubiquitin-like Modifiers (SUMO), their modification sites on substrate proteins cannot be identified using the mass spectrometry-based method that has been successful for identifying ubiquitination sites, unless a UBL protein is mutated accordingly. To identify UBL modification sites without having to mutate UBL, we have developed a dedicated search engine pLink-UBL on the basis of pLink, a software tool for identification of cross-linked peptide pairs. pLink-UBL exhibited superior precision, sensitivity, and speed than make-do search engines such as MaxQuant, pFind, and pLink. For example, compared to MaxQuant, pLink-UBL increased the number of identified SUMOylation sites by 50 ~ 300% from the same datasets. Additionally, we present a method for identifying small-molecule modifications of UBLs. This method involves antibody enrichment of a UBL C-terminal peptide following enrichment of a UBL protein, followed by LC-MS/MS analysis and a pFind 3 blind search to identify unexpected modifications. Using this method, we have discovered non-protein substrates of SUMO, of which spermidine is the major one for fission yeast SUMO Pmt3. Spermidine can be conjugated to the C-terminal carboxylate group of Pmt3 through its N1 or also likely, N8 amino group in the presence of SUMO E1, E2, and ATP. Pmt3-spermidine conjugation does not require E3 and can be reversed by SUMO isopeptidase Ulp1. SUMO-spermidine conjugation is present in mice and humans. Also, spermidine can be conjugated to ubiquitin in vitro by E1 and E2 in the presence of ATP. The above observations suggest that spermidine may be a common small molecule substrate of SUMO and possibly ubiquitin across eukaryotic species.

A novel strategy of protein engineering in dissecting SUMO interactions within the JAK / STAT pathway

Investigation of Protein Post-Translational Modifications with Site-Specifically Incorporated Non-Canonical Amino Acids

An Artificial Protein Modulator Reprogramming Neuronal Protein Functions

In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity

A Method For Sumo Modification Of Proteins In Vitro

Chemical Protein Synthesis Combined with Protein Cell Delivery Reveals New Insights on the Maturation Process of SUMO2

The Strategies for Identification and Quantification of SUMOylation

Signalling mechanisms and cellular functions of SUMO

SUMO conjugation – a mechanistic view

Versatile protein tag, SUMO: Its enzymology and biological function

Site-specific identification and quantitation of endogenous SUMOylation based on SUMO-specific protease and strong anion exchange chromatography

Global analysis of protein and small-molecule substrates of ubiquitin-like proteins (UBLs)

Regulation of IL-4-induced STAT6 activation by SUMOylation (P6307)

Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation

Q 7 A Progress in SUMO modification research

Development and Evaluation of a Highly Reliable Assay for SUMO-Specific Protease Inhibito R S

Research progression on biologic function and effect of SUMO-specific proteinase

SUMO proteases: from cellular functions to disease

Protein Engineering in the Ubiquitin System: Tools for Discovery and Beyond

Revealing USP7 Deubiquitinase Substrate Specificity by Unbiased Synthesis of Ubiquitin Tagged SUMO2

Antibody-free enrichment method for proteome-wide analysis of endogenous SUMOylation sites